First hospitalization for transient ischemic attack in France: Characteristics, treatments and 3-year outcomes

Revue neurologique
K CoskerPhilippe Tuppin

Abstract

Characteristics of patients hospitalized for transient ischemic attack (TIA) management before and during this hospitalization and follow-up are not well documented on very large populations. Among the 51 million beneficiaries of the French national health insurance general scheme (77% of French population), those subjects hospitalized for a first TIA in 2010 were included using the national health insurance information system (SNIIRAM). The frequencies of comorbidities during the previous five years and drug treatments received during the previous year and the first month after discharge were estimated from the SNIIRAM and then compared to data derived from the permanent randomized sample of all health insurance beneficiaries based on standardized morbidity ratios (SMR). The three-year outcome and factors associated with at least one readmission for TIA or ischemic stroke during the three months following the first hospitalization were investigated. A total of 18,181 patients were included (mean age: 69 years, 55% of women). The crude incidence of hospitalized TIA was 0.36 per 1000. Before hospitalization, patients presented a significantly higher rate of carotid and cerebral atherosclerosis (2.4% SMR=1.4), atrial fibrillation...Continue Reading

References

Sep 1, 2007·Journal of the Neurological Sciences·Yannick BejotMaurice Giroud
Nov 13, 2007·Lancet Neurology·Matthew F Giles, Peter M Rothwell
Jul 6, 2010·Revue D'épidémiologie Et De Santé Publique·P TuppinY Merlière
Sep 4, 2010·Stroke; a Journal of Cerebral Circulation·Annemarie D WijnhoudDiederik W J Dippel
Aug 13, 2011·Stroke; a Journal of Cerebral Circulation·Iacopo CancelliMariarosaria Valente
Sep 3, 2011·Stroke; a Journal of Cerebral Circulation·Amytis TowfighiBruce Ovbiagele
Jan 13, 2012·Cerebrovascular Diseases·F PurroyUNKNOWN Stroke Project of the Spanish Cerebrovascular Diseases Study Group
Oct 26, 2012·Cerebrovascular Diseases·Jaime Díaz-GuzmánUNKNOWN IBERICTUS Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group
Nov 20, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Yannick BéjotMaurice Giroud
Dec 7, 2013·Stroke; a Journal of Cerebral Circulation·Daniel T LacklandUNKNOWN Council on Functional Genomics and Translational Biology
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Sep 27, 2014·Stroke; a Journal of Cerebral Circulation·Vijaya SundararajanVelandai K Srikanth

❮ Previous
Next ❯

Citations

May 26, 2017·Pharmacoepidemiology and Drug Safety·Julien BezinNicholas Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.